Journal article
Potential Masking Effects of Salmeterol on Airway Inflammation in Asthma
Abstract
We hypothesized that regular use of long-acting beta-agonists could delay recognition of ("mask") increasing airway inflammation. We studied steroid-sparing and "masking" effects of salmeterol versus placebo in 13 asthmatic individuals requiring >= 1,500 microgram inhaled corticosteroid daily. Corticosteroid doses were reduced weekly until criteria were met for an exacerbation or the corticosteroid was fully withdrawn. Subjects were …
Authors
ANDREW McIVOR R; PIZZICHINI E; TURNER MO; HUSSACK P; HARGREAVE FE; SEARS MR
Journal
American Journal of Respiratory and Critical Care Medicine, Vol. 158, No. 3, pp. 924–930
Publisher
American Thoracic Society
Publication Date
September 1, 1998
DOI
10.1164/ajrccm.158.3.9802069
ISSN
1073-449X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, InhalationAdrenergic beta-AgonistsAdultAlbuterolAnti-Asthmatic AgentsAsthmaBeclomethasoneBlood ProteinsBronchial Provocation TestsBronchitisBronchoconstrictor AgentsBronchodilator AgentsBudesonideCross-Over StudiesDisease ProgressionEosinophil Granule ProteinsEosinophilsFemaleGlucocorticoidsHumansInflammation MediatorsLeukocyte CountMaleMethacholine ChlorideMiddle AgedPeak Expiratory Flow RatePlacebosRibonucleasesSalmeterol XinafoateSpirometrySputum